Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Biorxiv : the Preprint Server for Biology|April 24, 2023
Non-specific recognition of histone modifications by H3K9bhb antibodyTakeshi Tsusaka, Juan A Oses-Prieto, Christina Lee, et al.
Poultry Science|August 3, 2014
Alginate-whey protein dry powder optimized for target delivery of essential oils to the intestine of chickensY Zhang, J Gong, H Yu, et al.
Viruses|February 28, 2023
Retroviral Infection and Commensal Bacteria Dependently Alter the Metabolomic Profile in a Sterile OrganJessica Spring, Vera Beilinson, Brian C DeFelice, et al.
Analytical Chemistry|February 23, 2017
Mass Spectral Feature List Optimizer (MS-FLO): A Tool To Minimize False Positive Peak Reports in Untargeted Liquid Chromatography-Mass Spectroscopy (LC-MS) Data ProcessingBrian C DeFelice, Sajjan Singh Mehta, Stephanie Samra, et al.
Iscience|July 24, 2023
Non-specific recognition of histone modifications by H3K9bhb antibodyTakeshi Tsusaka, Juan A Oses-Prieto, Christina Lee, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 13, 2019
Utilizing cooled liquid chromatography and chemical derivatization to separate and quantify C3-epimers of 25-hydroxy vitamin D and low abundant 1α,25(OH)2D3: Application in a pediatric populationBrian C DeFelice, Theresa L Pedersen, Hanan Shorrosh, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 19, 2015
Investigation of metabolomic blood biomarkers for detection of adenocarcinoma lung cancerJohannes F Fahrmann, Kyoungmi Kim, Brian C DeFelice, et al.
Cancer Biomarkers : Section a of Disease Markers|March 23, 2016
Serum phosphatidylethanolamine levels distinguish benign from malignant solitary pulmonary nodules and represent a potential diagnostic biomarker for lung cancerJohannes F Fahrmann, Dmitry Grapov, Brian C DeFelice, et al.
Pediatric Diabetes|July 21, 2020
Metabolomics-related nutrient patterns at seroconversion and risk of progression to type 1 diabetesRandi K Johnson, Lauren A Vanderlinden, Brian C DeFelice, et al.
Clinical Proteomics|November 2, 2016
Proteomic profiling of lung adenocarcinoma indicates heightened DNA repair, antioxidant mechanisms and identifies LASP1 as a potential negative predictor of survivalJohannes F Fahrmann, Dmitry Grapov, Brett S Phinney, et al.
Pageof 5